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Abstract Studies on inducible ascidian lectins may shed
light on the evolutionary emergence of cytokine functions.
Here, we show that the levels of opsonins, with IL1α-
epitopes, increase in Ciona intestinalis hemolymph as a
response to an inflammatory stimulus and, in particular, to
intratunic injection of lipopolysaccharide (LPS). The inflam-
matory agent promptly (within 4 h) enhances Ca2+-indepen-
dent serum hemagglutinating and opsonizing activities,
which are both inhibited by D-galactose and D-galactosides
(α-lactose, N-acetyl-D-lactosamine, thio-digalactoside), sug-
gesting that anti-rabbit erythrocyte lectins with galectin
properties are involved as opsonins. Inducible galectin
molecules contain interleukin-1α (IL1α) epitopes, and their
activities are specifically inhibited by anti-human recombi-
nant IL1α antibody. Analysis by SDS-polyacrylamide gel
electrophoresis has revealed that the density of the bands of
several serum proteins increases within 4 h after LPS
injection, correlated with the enhanced serum activity.
Moreover, Western blot patterns demonstrate that several
serum proteins (59, 37, 30, 23, 15 kDa) cross-react with the
antibody as early as 4 h post-injection. Although we have
not been able to establish whether, in adition to galectins,
various types of D-galactose-specific lectins are contained in
the serum, we show, for the first time in invertebrates, that
galectin molecules with opsonic properties can be enhanced
in response to a non-specific inflammatory stimulus, and that
their release can be further stimulated by LPS. Finally, we
reveal that multiple galectins share human IL1α epitopes,
probably because of steric configuration and the oligomer-
ization process.
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Introduction
In the invertebrate immune system, phagocytosis, cell
proliferation, and chemotaxis can be regulated by cytophilic
humoral molecules with functional similarities to vertebrate
cytokines (Beck and Habicht 1996; Beck et al. 1993;
Beschin et al. 2004). These molecules modulate defense
responses to exogenous and endogenous insults, tissue repair,
and the recovery of homeostasis through binding to specific
cell-surface ligands and receptors. Many mammalian cyto-
kines are bifunctional molecules containing a receptor-
binding domain and an evolutionarily conserved carbohydrate
recognition domain (CRD) that is typical of lectins and that
associates with carbohydrates for biological activity (Beschin
et al. 2004). In this regard, interleukins IL1α and β can be
considered as lectins (Cebo et al. 2001a, b, 2002) directly
interacting with various pathogens through lectin-like inter-
actions and contributing to pathogen elimination via opso-
nization and/or leukocyte activation (Zanetta et al. 1996,
1998; George 1994; Luo et al. 1993; Lucas et al. 1994;
Magez et al. 2001). CRDs with various ranges of sugar
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binding characterize many invertebrate and vertebrate lectins
and form an ancestral protein-carbohydrate recognition
system that has been implicated in inflammation and several
immune responses (White 1987; Söderhall and Smith 1986;
Vasta et al. 2004).
Lectins, identified by their hemagglutinating activity
(HA) and sugar specificity, are divided into structurally
related protein families and superfamilies (Drickamer and
Taylor 1993; Dodd and Drickamer 2001; Sharon and Lis
2003). In general terms, two main animal lectin types have
been distinguished: Ca2+-dependent lectins (C-type) with a
diverse sugar specificity and whose cysteine residues form
disulfide bridges; Ca2+-independent lectins (S-type/galec-
tins), which are small soluble lectins that have CRDs with
affinity for β-galactosides, and which contain cysteine
residues that do not form disulfide bridges. Of critical
importance for galectin characterization is the binding
specificity of the basic unit of recognition, as shown by
the relative inhibitory efficiency of key oligosaccharides
such as α-lactose, N-acetyl-D-lactosamine (Lac-NAC), and
thio-digalactoside (TDG) T-disaccharide (Galβ1, 3GalNAc;
Dodd and Drickamer 2001; Sharon and Lis 2003; Cooper
and Barondes 1999).
Since tunicates are considered a key group in chordate
phylogenesis (Hori and Osawa 1987; Field et al. 1988;
Zeng and Swalla 2005; Delsuc et al. 2006), studies on
inducible ascidian lectins with cytokine functions may shed
light on the evolutionary emergence of inflammatory
molecules, which may be related to similar molecules in
vertebrates. In this respect, multiple naturally occurring
soluble ascidian lectins, usually named “tunicate” cyto-
kines, mediate broad recognition and effector immune
responses by presenting some functional cytokine proper-
ties (Vasta et al. 2004; Beck et al. 1989; Quesenberry et al.
2003). In the hemolymph of the ascidians Styela clava and
S. plicata, “cytokine-like” proteins stimulate cell prolifera-
tion in pharyngeal explants (Nair et al. 2001; Raftos and
Cooper 1991) and modulate phagocytic activity of tunicate
hemocytes (Beck et al. 1993). Both 17-kDa tunIL1 and 14-
kDa molecules have been identified as Ca2+-dependent C-
type lectins that bind galactosyl moieties and opsonize
yeast (Beck et al. 1993; Nair et al. 2001; Kelly et al. 1992).
The tunIL1 of S. clava also stimulates the proliferation of
mouse thymocytes and L-929 fibroblasts (Raftos and
Cooper 1991), exerting its IL1-like activity through a
galactosyl-binding site (Raftos 1996; Raftos and Nair
2004). C-type lectins of Clavelina picta and Halocynthia
roretzi modulate cellular activity by enhancing cell prolif-
eration and phagocytosis (Raftos et al. 2001); furthermore,
H. roretzi lectin stimulates superoxide anion production by
hemocytes (Abe et al. 1999).
Several ascidian galectins have been identified. In C.
picta, a prototype galectin has been characterized (Vasta
et al. 2004). In Didemnum candidum, a galactosyl-binding
lectin shows mitogenic activity toward murine thymocytes
(Vasta et al. 1986). Finally, a “galectin-like” opsonin has
been reported in colonial Botryllus schlosseri (Ballarin et al.
1994, 2000).
In mammals, various galectin immunomodulative activ-
ities have been established; galectins appear to be pro-
inflammatory cytokines released when immune responses
are triggered. Therefore, the release of lectin in invertebrate
inflammatory events represents an additional functional
approach to studying ascidian immunomodulatory mole-
cules. To date, we know that a S. plicata C-type lectin
appears to act in a pro-inflammatory manner and can be
enhanced as an acute-phase antigen-recognition protein by
zymosan injection, which causes an inflammatory response
resembling that of mammalian collectins (Green et al.
2003), whereas no data have been reported on the
modulation of galectin release.
In Ciona intestinalis, naturally occurring C-type and S-
type lectins are contained in the hemolymph (Parrinello and
Patricolo 1975; Wright 1981). Moreover, C-type lectins and
galectins have been recorded in the genome of C.
intestinalis (Dehal et al. 2002), and a 36-kDa β-galacto-
side-binding lectin gene is expressed in hemocytes (Shida
et al. 2003). This ascidian shows a strong inflammatory
reaction just after erythrocytes or foreign proteins are
injected into the tunic. Parrinello and collaborators
(Parrinello 1981; Parrinello et al. 1984a, b) have reported
that numerous hemocytes of various types, including
phagocytes, promptly infiltrate the tunic tissue, and a
capsule becomes visible by eye at the injection site within
2–3 days. The inflammatory reaction has also been
revealed by tunic tissue injury that might mask the capsule
in a percentage of treated ascidians depending on the dose
of inflammatory agent (Parrinello et al. 1984a, b) and by
massive degranulation of hemocytes (Parrinello et al. 1990).
Among experimental approaches used to identify inver-
tebrate cytokine molecules, antibodies neutralizing the
activity of mammalian cytokines have been used to screen
for cross-reactivity with factors in hemolymph, immuno-
cytes, neuroendocrine cells, and tissues (for a review, see
Beschin et al. 2004). In eight North American species of
tunicates, molecules with an IL1 function have been
neutralized by polyclonal anti-human IL1 antisera (Beck
et al. 1989).
In the present paper, we show that lipopolysaccharide
(LPS) injection induces a capsule in the C. intestinalis
tunic, whereas in the hemolymph, the concentration of
lectins showing IL1α epitopes and the opsonizing property
is promptly (within 4 h) augmented as a response to the
non-specific inflammatory stimulus. LPS further enhances
serum HA and opsonizing activities, revealing its inflam-
matory effect in triggering the release of the active
Cell Tissue Res
molecules. The D-galactoside specificity and Ca2+-inde-
pendent activities of naturally occurring and inducible
hemagglutinins and opsonins suggest that they possess
galectin properties. Since specific antibodies abolish op-
sonic activity and significantly decrease HA, we suggest
that galectin-like serum fractions are provided with IL1α
epitopes. Finally, electrophoretic and immunoblotting pat-
terns support the idea that multiple serum proteins with
IL1α epitopes can be enhanced in the hemolymph,
correlating with serum activity, as a response to LPS
challenge.
Materials and methods
Tunicates
C. intestinalis were collected from Sciacca Harbor (Sicily,
Italy). Prior to experimentation, tunicates were held for up
to 2 days in refrigerated glass aquaria (60 l, 15°C, filtered
seawater) and fed every second day with a marine
invertebrate diet.
LPS injection
LPS (Escherichia coli 055:B5) solution was prepared in
sterile marine solution (MS: 12 mM CaCl2.6H2O, 11 mM
KCl, 26 mM MgCl2.6H2O, 45 mM TRIS, 38 mM HCl,
0.45 M NaCl, pH 7.4). A volume of 100 μl of 1 mg/ml LPS
solution (100 μg LPS per animal) was injected into the
tunic tissue at the median body region, whereas untreated
and MS (100 μl)-treated ascidians served as controls.
Before injection, the tunic surface was thoroughly cleaned.
All the solutions were filtered through a 0.22-μm filter
(Millipore, Millex) and were autoclaved.
Cell-free hemolymph (serum) preparations
The animals were blotted dry to remove any excess
seawater and bled by removal of the tunic and puncture
of the heart. The hemolymph was withdrawn from the heart
with a sterile syringe and immediately centrifuged at 800g
(10 min, 4°C). The supernatant (serum) was filtered
through a 0.45-μm filter (Millex GV, Millipore). At every
time-point, serum pools from ten individuals were prepared,
divided into small aliquots, and kept at −80°C.
Yeast preparation and opsonization, and in vitro
phagocytosis assay
A Saccharomyces cerevisiae (baker’s yeast, type II)
suspension was prepared in distilled water at 0.25% w/v
(approximately 1×108 yeast/ml), autoclaved for 15 min,
washed twice by centrifugation at 2,000g (5 min, 4°C), and
finally incubated for 2 h at 20°C with a solution of eosin-Y
at a final concentration of 0.05% (Cammarata and Arizza
1994). After repeated washes, the yeast were suspended in
sterile calcium-free and magnesium-free MS (f-MS) at a
final concentration of 0.125% and used immediately.
For opsonization, yeast were incubated with serum
(0.125% w/v) for 1 h at 20°C, washed in f-MS (3 times),
and finally suspended in f-MS at the initial concentration.
After this treatment, the yeast appeared to be agglutinated,
forming small clumps, but they were easily re-suspended
by washes with f-MS.
To verify the role of divalent cations in opsonin-yeast
binding, opsonization was carried out in the presence of
20 mM ethylenediaminetetraacetic acid (EDTA). Further-
more, the effect of added Ca2+ was estimated with TRIS-
buffered saline (TBS) containing 10 mM CaCl2. For the
phagocytosis assay, 200 μl hemocyte suspension (1×106
cells in MS, indicated as He) from unchallenged ascidians
was mixed with 100 μl yeast preparation (10:1 yeast/
hemocyte ratio) and incubated in 1-ml plastic test-tubes
under gentle stirring for 90 min at 20°C. Then, 50 μl
quenching solution (2 mg/ml trypan blue, 2 mg/ml crystal
violet in 0.02 citrate buffer, pH 4.4, containing 33 mg/ml
NaCl) was added. A drop of this suspension was smeared
onto slides and examined under a Leica Diaplan Epifluo-
rescence microscope (Leica, Wetzlar, Germany). Hemocytes
(about 1,000 for every assay, and at least 200/slide) were
counted at 800× magnification. Serum opsonizing capacity
was expressed as the percentage of hemocytes showing
ingested yeast over the total number of hemocytes. Results
were compared with the percentage of phagocytes with
engulfed yeast in a reaction mixture in which hemocytes from
unchallenged ascidians were mixed with non-opsonized yeast.
Hemagglutination assay
Rabbit erythrocytes (RE) were obtained from the Instituto
Zooprofilattico della Sicilia (Palermo). The erythrocyte
pellet was washed with phosphate-buffered saline (PBS,
pH 7.4), centrifuged at 500g for 10 min at 4°C, and then
resuspended in TBS (TRIS-HCl 50 mM, NaCl 0.15 M, pH
7.4) to obtain a 1% suspension.
As previously reported (Parrinello and Canicattì 1982),
serum HA was determined in 96-well round-bottomed
microtiter plates by using TBS containing 0.1% gelatin as
the dilution medium and an equal volume of 1% RE in
TBS. To increase the erythrocyte sensitivity to the
hemagglutination assay, trypsin-treated erythrocytes (try-
RE) were prepared by resuspending an RE pellet (obtained
from 1.0 ml blood) in 6 ml TBS containing 300 μg trypsin
(stock solution prepared in 10 mM HCl). The reaction
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mixture was incubated at 37°C for 15 min. The try-RE were
washed with TBS and resuspended (1%) in TBS. To verify
the role of Ca2+, the hemagglutination assay was carried out
in the presence of 20 mM EDTA or 10 mM CaCl2.
The titer of HA (HT) was expressed as the reciprocal of
the highest dilution giving unequivocal agglutination
judged by eye or with a low-power binocular microscope.
The HT values, expressed as log2, were recorded as the
average (±SD) of 10 different assays. Controls consisted of
TBS samples in which serum was not added.
Sugar inhibition of serum activities
Serum was incubated for 30 min at 20°C with decreasing
sugar concentrations (starting from a 100-mM final con-
centration), avoiding serum dilution. The treated serum was
assayed for HA. The lowest sugar concentration (in mM)
that abolished the HA of the serum was recorded. For
opsonization, yeast were maintained for 1 h in sugar-
containing serum and then washed (twice) with f-MS
before the phagocytosis assay. The lowest sugar concentra-
tion (in mM) giving significant inhibitory activity was
recorded. D-galactose, α-lactose, D-mannose, D-glucose,
L-fucose, N-acetyl-D-lactosamine (Lac-NAc), and thio-
digalactoside (TDG) were assayed.
To examine the effect of sugar added to the yeast
suspension, 25 μl opsonizing serum containing 100 mM
sugar was mixed on a slide with 25 μl yeast suspension
and, after a 1.5-h incubation in a moist chamber, were
observed by using a microscope equipped with Nomarski
differential interference contrast optics (Leica). The sugar
effect was observed by comparing the significant de-
crease (up to 10%) in the percentage of phagocytes
showing ingested yeast.
Absorption of serum by yeast, erythrocytes, and anti-human
recombinant interlekin-1 antibodies
Serum was absorbed by packed yeast or erythrocytes by
incubating (1 h at 20°C) 50 μl serum with an equal volume
of the target pellet. After centrifugation of the mixture at
500g (15 min at 4°C), the absorbed sera were used for
opsonization and hemagglutination assays.
To check for IL1α epitopes, commercial antibodies raised in
rabbit against human recombinant interleukin-1α (IgG fraction
of antiserum; anti-hrIL1α) were used in sterile PBS (7 mg/ml
IgGs). Serum (50 μl) was mixed (v/v) with various dilutions
of IgGs (3.5 mg/ml, 1.75 mg/ml, 0.87 mg/ml final concentra-
tion), incubated at room temperature for 1 h and overnight at
4°C, and then centrifuged at 27,000g (30 min, 4°C).
The opsonizing capacity of the absorbed serum was
compared with the activity of a two-fold diluted serum from
untreated ascidians.
Specificity of antibody reaction
To check whether non-specific rabbit IgGs cross-reacted with
serum proteins, specific antibodies were replaced by the
following rabbit IgG preparations: (1) anti-C. intestinalis type
IX-like collagen (anti-CiIXcollagen) antiserum prepared by
Sigma Genosis by using a synthetic peptide as the antigen
(Vizzini et al. 2000); (2) anti-fish fucolectin whole rabbit
antiserum (anti-DlFL) prepared by Sigma Genosis by using a
synthetic peptide of a sequenced fish (Dicentrarchus labrax)
fucolectin as the antigen (Cammarata et al. 2001); (3) anti-
goat IgGs (2.3 mg/ml).
Finally, 100 μl anti-hrIL1α IgGs (700 μg) were
absorbed overnight at 4°C with 10 μl hrIL1α (0.4 μg;
Sigma-Aldrich) in PBS and centrifuged at 27,000g for
45 min at 4°C. Non-absorbed anti-hrIL1α IgG at the same
dilution of the absorbed IgG was used as a control in
Western blot assays.
In silico sequence analysis
To check the hrIL1α epitopes contained in galectins
reported in the genome of C. intestinalis (JGI v 2.0), a
pairwise alignment algorithm (Water program of the
EMBOSS package; Rice et al. 2000) was used for
comparing the whole length of IL1α (excluding the
propeptide) and the galectin deduced amino acid sequences.
Polyacrylamide gel electrophoresis
SDS-polyacrylamide gel electrophoresis (SDS-PAGE;
15%) was performed according to the method of Laemmli
(1970); proteins were stained with Coomassie Blue. Gels
were calibrated with molecular mass markers (Sigma-
Marker low range 6.5-66 kDa), and the molecular weight
was calculated as the mean of five distinct analyses. Before
electrophoresis, samples were boiled for 5 min in sample
buffer containing 5% β-mercaptoethanol as a reducing
agent.
Western blot analysis with anti-hrIL1α
Following SDS-PAGE, the gel was soaked in transfer
buffer (20 mM TRIS, 150 mM glycine, pH 8.8) for 10 min,
and the proteins were transferred (1 h at 210 mA) to a
nitrocellulose sheet in transfer buffer. After being blotted,
membranes were blocked overnight with 5% w/v bovine
serum albumin (BSA) in PBS containing 0.05% Triton X-100
for 2 h. Blocked membranes were incubated with anti-hrIL1α
antibodies (1:1,000 in PBS) for 1 h, washed with blocking
buffer, and incubated (1 h) with alkaline-phosphatase-
conjugated mouse anti-rabbit IgG (1:8,000 in blocking
buffer). Blots were washed with PBS and developed with
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5-bromo-4-chloro-3-indolyl phosphate/nitro-blue tetrazolium
(BCIP/NBT) according to the manufacturer’s instructions.
Primary antibodies were omitted in controls.
Protein determination
Quantitative protein analysis was performed according to
Bradford (1976), using BSA as a standard. Each value was
expressed as the means of three measurements (±SE).
Chemicals and preparation of sterile solutions
Unless otherwise indicated, all chemicals were from Sigma-
Aldrich (St Louis, Mo.). Before use, salt solutions and
media were filtered with a 0.22-μm filter (Millex GV,
Millipore) and autoclaved.
Statistical analysis
Data were analyzed by one-way analysis of variance
(ANOVA). Comparisons between different groups were
carried out by the Tukey t-test. P<0.05 was considered as
being statistically significant. Standard deviations were
calculated based upon 10 experiments.
Results
Inflammatory response following challenge
by LPS injection
Within 4–24 h post-injection (p.i.) with LPS, a whitish
halo (capsule, 0.5–1.0 cm wide) was visible at the
injection site through the transparent tunic. In ten
separate experiments on a total of 800 ascidians, an
average of 52.6±15% of 800 ascidians showed a capsule
after 4–12 hours p.i., whereas tunic tissue injury was
observed in 18.5±8% tunicates. Ascidians (200 in total)
injected with MS alone presented no visible response
throughout the experiments. Variability in the time of the
response, reaction intensity, and percent of responders
was observed between experiments.
MS or LPS injection promptly enhances serum opsonizing
capacity against yeast, and serum HA against try-RE
As shown in Fig. 1, 10% (mean value) of hemocytes from
untreated ascidians (He) spontaneously ingested non-
opsonized yeast. When the targets were opsonized with
serum from untreated ascidians (henceforth indicated as S),
a greater number of hemocytes contained engulfed yeast,
and the percentage significantly increased by up to 15% (P<
0.05 vs He). The percentage of hemocytes with ingested
yeast reached 21%–23% (significant at P<0.001 vs He)
when yeast were opsonized with sera prepared from
ascidians just after injection of MS (indicated as MS-0h)
or LPS (indicated as LPS-0h). Although these last-men-
tioned results are referred to as being obtained at time 0 in
Fig. 1, 5–15 min had elapsed while the animals were bled,
and the serum was prepared.
In ten experiments, the response profile of ascidians
treated with MS or LPS revealed that the mean serum
opsonizing activity was higher at 2 h p.i., reached a
maximum at 4 h p.i. (serum indicated as LPS-2h and
LPS-4h, respectively, in text) and, within 24 h, decreased to
the level registered at the beginning of the response. This
last level was maintained until 48 h (data not shown),
whereas S showed a lower activity (12%–15%) throughout
the duration of the experiments. The inflammatory effect of
LPS was revealed by the significantly (P<0.001) higher
opsonizing capacity of LPS-4h (34%) compared with that
of serum prepared at 4 h from ascidians injected with MS
(24%; indicated as MS-4h in text; Fig. 1).
The Ca2+-independence of the opsonizing activity was
shown by treating yeast with S, MS-4h, or LPS-4h in the
presence of 20 mM EDTA or TBS/10 mM CaCl2. In all
cases, no differences were observed between samples with
or without Ca2+ (data not shown). Finally, opsonins were
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Fig. 1 Time course of opsonizing capacity of Ciona intestinalis
serum against yeast, after injection of marine solution (MS) or LPS
(100 μg/ascidian), compared with the serum activity of untreated
ascidians. Hemocytes from untreated ascidians were used in a
phagocytosis assay (Phagocytosis (%) per cent hemocytes containing
ingested yeast, hatched bar percent hemocytes from unchallenged
ascidians that spontaneously ingested non-opsonized yeast [He], open
squares sera prepared after LPS [100 μg/ascidian] injection, open
diamonds sera prepared after MS injection, filled squares sera from
untreated ascidians held under the same experimental conditions as the
injected animals [S], open triangles sera from ascidians injected with
LPS and opsonins absorbed with rabbit erythrocytes treated with
trypsin [try-RE], open circles sera from ascidians injected with MS
and opsonins absorbed with try-RE). Inset: Tukey t-test comparison
between the various groups. ***P<0.001
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absorbed by treating MS-4h or LPS-4h with packed try-RE
added (v/v) to serum (Fig. 1).
As demonstrated in Fig. 2, the mean HT significantly (P<
0.01) increased from the value of 2 obtained for serum from
untreated ascidians up to the value of 3 found for serum
prepared just after LPS or MS injection. Higher values, close
to 4 HT (P<0.001), were observed for serum prepared at 2 h
from MS injection (MS-2h) and for LPS-2h. Finally, the
highest titers (close to 5) were found for LPS-4h. High titers
(about 4) were maintained until 48 h (data not shown). The
serum HA of untreated ascidians did not change throughout
the experiment (24 h). Although a wide variability charac-
terized HT values from different experiments, the enhancing
effect of LPS was revealed by the significant (P<0.05)
difference between the HTs observed for the serum from
LPS-treated ascidians and those found for the serum from
MS-treated ascidians.
Absorption of S, MS-4h, and LPS-4h by yeast signifi-
cantly (P<0.001) decreased the HA (Fig. 2), whereas the
presence of 20 mM EDTA or 10 mM CaCl2 did not affect
the HTs (data not shown).
D-galactose and D-galactosides inhibit serum opsonizing
activity and HA
The opsonic capacity of LPS-4h was inhibited after treat-
ments with 50.0 mM D-galactose, 50.0 mM α-lactose,
50.0 mM D-mannose, 25.0 mM N-Lac-NAc, and 17.5 mM
TDG, whereas D-glucose and L-fucose at 100 mM did not
exert any inhibitory effect (Table 1). To ascertain whether
the decreased serum opsonizing capacity could be attributed
to an effect of the sugars on targets, yeast were incubated
(30 min, 20°C) with 100 mM sugar in f-MS before
opsonizing treatment. None of the tested sugars affected
the opsonization.
The HA of LPS-4h was abolished by 22.5 mM D-
galactose, 10.5 mM α-lactose, 9.4 mM LacNAc, and
0.7 mM TDG, whereas it was not affected by 100 mM D-
mannose, D-glucose, or L-fucose (Table 1). The same sugar
concentrations inhibited any opsonizing activity and HA of
S and MS-4h.
Anti-hrIL1α polyclonal antibodies abolish serum
opsonizing activity and decrease HA
Antibodies (3.5 mg/ml total rabbit IgGs) abolished serum
opsonizing activity and significantly decreased HA. The
LPS-4h and MS-4h opsonizing capacity dropped down to
the He level (Fig. 3), and this effect was dose-dependent
(Fig. 4). Inhibition was not an effect of anti-hrIL1α
antibodies on the yeast suspension because, after pre-
treatment with anti-hrIL1α IgGs, the yeast suspension
showed no clumps (microscopic observations), and the
same yeast could be opsonized later (data not shown).
Likewise, the antibody treatment significantly decreased the
HA of MS-4h and LPS-4h (Fig. 3). Rabbit immune serum
toward CiIX collagen or fish fucolectin (DlFL) and rabbit
IgGs did not inhibit the opsonizing activity and HA
(Fig. 4). In addition, both activities were maintained by
treating LPS-4h with anti-hrIL1α antibody preparation
absorbed with hrIL1.
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Fig. 2 Time course of hemagglutinating activity (HA) of C.
intestinalis serum against try-RE after injection of MS or LPS
(100 μg/ascidian) compared with the activity of serum from untreated
ascidians open squares sera prepared after LPS [100 μg/ascidian]
injection, open diamonds sera prepared after MS injection, filled
squares sera from untreated ascidians held under the same experi-
mental conditions as the injected animals, open triangles sera from
ascidians injected with LPS and opsonins absorbed with try-RE, open
circles sera from ascidians injected with MS and opsonins absorbed
with try-RE. Inset: Tukey t-test comparison between the various
groups. ***P<0.001, **P<0.01
Table 1 Sugar inhibition of Ciona intestinalis serum opsonizing and
hemagglutinating activities (HA hemagglutinating activity, GalD-
galactose, Lacα-lactose, ManD-mannose, GluD-glucose, FucL-fucose,
LacNacN-acetyllactosamine, TDGthiodigalactoside, N.I. no inhibition)
Sugar Phagocytosis HA
LPS-4ha
Gal 50.0±3.1 22.5±4.3
Lac 50.0±1.2 10.5±2.8
Man 50.0±2.5 N.I.
Glu N.I. N.I.
Fuc N.I. N.I.
LacNAc 25.0±1.5 9.4±4.4
TDG 17.5±2.7 0.7±0.2
a LPS-4h (serum at 4 h from LPS injection): the lowest sugar
concentration (mM) that abolished the HA of the serum against
rabbit erythrocytes or giving significant inhibitory activity of yeast
opsonization was recorded (starting sugar concentration: 100 mM)
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SDS-PAGE and immunoblotting analyses reveal inducible
serum proteins provided with IL1α epitopes at 4 h
after LPS injection
Sera from LPS-treated ascidians, examined by SDS-PAGE,
revealed several protein components scarcely visible in the
serum pattern of untreated ascidians (Fig. 5a). Although all
samples were adjusted to a 4 μg protein content, the LPS-
4h pattern presented several proteins (59.2±0.3, 37.1±0.9,
30.5±0.7, 27.4±0.5, 23.3±0.3, 20.1±0.4, 15.1±0.6, 8.7±
0.4 kDa; n=5) characterized by a differently increased band
density as compared with the S and MS-4h (bands scarcely
visible), LPS-2h (low band density), and LPS-8h (density
significantly decreased) patterns (Fig. 5b). For LPS-4h, the
37.1-kDa and 15.1-kDa bands were mainly enhanced, and
minor bands (59.2±0.3 and 43.0±0.1 kDa) were barely
visible.
In immunoblotting analysis, some serum proteins that
formed the SDS-PAGE pattern of LPS-4h (59.2, 37.1, 30.5,
23.3, 15.1 kDa) cross-reacted with anti-hrIL1α antibodies
(Fig. 5c). The density of these bands appeared to be visibly
augmented compared with those at LPS-2h, LPS-8h, and
LPS-12h; among them, the 37.1-kDa and 15.1-kDa bands
presented the highest density. For the MS-4h serum, only
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23.3-kDa and 30.5-kDa bands were clearly visible (Fig. 5c),
whereas for the serum from untreated ascidians, only the
23.3-kDa band was observed (Fig. 5a). To check for the
specificity of the antibody reaction, a control immunoblot
performed with rabbit immune antisera against fish fuco-
lectin (DlFL), CiIX collagen, rabbit IgGs, and anti-hrIL1α
IgGs absorbed with hrIL1α revealed no reaction with
serum components of LPS-4h (Fig. 5d).
Two traits of deduced hIL1α amino acid sequences
show similarity with galectin CRDs
Whole-length alignment of the deduced human IL1α and C.
intestinalis galectin amino acid sequences (propeptide ex-
cluded) showed similarity of 62.5% between the IL1α 110-
117 trait and 39–46 trait of the fgenesh3_pg. C_scaffold_
7960000001 (galectin ID 235601, CRDI; Table 2). A further
similarity (66.7%) was observed between IL1α 213–223 trait
of the motif 2 and 204–214 trait of the fgenesh3_pg.
c_chr_06q000046 (galectin ID 216812, CRDII).
Discussion
In ascidians, cytokine-like molecules have been discovered
by functional cell proliferation and opsonization studies,
but the cross-reactivity of anti-mammal IL1 antibodies with
ascidian hemolymph humoral components (Beck et al.
1989) remains unclear. Recent reports of a genome-wide
analysis of C. intestinalis have provided a comprehensive
picture of immune-related genes (Dehal et al. 2002; Shida
et al. 2003; Azumi et al. 2003; Terajima et al. 2003) and
shown that IL1 genes are not contained in the genome,
whereas the recorded C-type lectin and galectin genes can
be expressed by hemocytes from untreated ascidians (Shida
et al. 2003; Azumi et al. 2003).
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Fig. 5 SDS-PAGE (15%, under reducing conditions) and Western
blotting analyses with anti-hrIL1α antibodies of serum proteins in C.
intestinalis hemolymph at various times (hour) from LPS injection
compared with serum from untreated or MS-treated ascidians. (S
serum from untreated ascadians, MS-4 4 h from MS injection, LPS
(hour) serum samples at 2, 4, 8, and 12 h after LPS injection. a SDS-
PAGE and Western blot analyses of serum from ascidians. b SDS-
PAGE of serum from treated ascidians. c Western blot analysis of
serum from MS- and LPS-treated ascidians. d Western blot analysis of
ascidian serum at 4 h from LPS injection, with non-specific rabbit
IgGs or anti-hrIL1α antibodies absorbed with hrIL1α. Gels calibrated
with Sigma-Marker low range 6.5-66 kDa
Table 2 Pairwise best-region alignment of deduced amino acid
sequence between human interleukin 1α mature peptide and putative
galectin genes from the genome of C. intestinalis (CRD carbohydrate
recognition domain, Motif 2 conserved element from IL1α sequence
[PRINTS-S database accession no. PR00264]) obtained by using the
Water program of the EMBOSS package [human interleukin 1α (GenBank
accession no. NP-000566), C. intestinalis genome (DOE Joint Genome
Institute version 2.0) assigned name: galectin ID 216812 (fgenesh3_pg.
c_chr_06Q000046); galectin ID235601 (fgenesh3_pg.c _scaf-
fold_7960000001)]
Sequence name Alignment Similarity/identity (%) Region
Interleukin 1α 110 kprsapfs 117
||.|..|| 62.5/62.5
Galectin (235601) 39 KPSSEGFS 46 CRD I
Interleukin 1α 213 titgsetnllf 223 Motif 2
||.|..|...| 54.5/45.5
Galectin (216812) 204 TIIGRATAHMF 214 CRD II
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The inflammatory reaction in the tunic of C. intestinalis
(Parrinello 1981; Parrinello et al. 1984a, b, 1990) is a
suitable model for the examination of inducible humoral
cytokine-like factors. We have therefore stimulated a response
to LPS in this ascidian that induces cytokine expression and
release in mammals. In accordance with previous results
(Parrinello 1981; Parrinello et al. 1984a, b), MS injected into
the tunic does not cause any visible inflammatory reaction,
whereas within few hours (4–24 h), LPS induces the
formation of a visible capsule in a large percentage of the
treated ascidians, and, less significantly, tissue injury that
represents a more intense response that masks the capsule.
The variability in time and intensity of the response might be
related to the different ascidian batches gathered at various
times during the course of our research.
According to Parrinello et al. (1990), the early inflam-
matory response of C. intestinalis recruits phagocyte
populations into the inflamed tissue (Parrinello et al.
1984a, b); consequently, mitogenic, chemotactic, and
opsonic factors are probably responsible for cell prolifera-
tion in the hemopoietic nodules under the tunic, for
hemocyte recruitment, and for the stimulation of inflam-
matory responses, including enhanced phagocytosis and
encapsulation. Pinto et al. (2003) have reported that,
following intratunic LPS injection in this ascidian, chemo-
tactic activity is exerted by a “C3a-like” peptide expressed
by tunic hemocytes following the activation of a comple-
ment-like pathway.
The serum hemolymph from untreated C. intestinalis
displays a naturally occurring opsonizing capacity with
respect to yeast, which, even after repeated washes, become
more susceptible to in vitro phagocytosis by hemocytes
from untreated ascidians. Immediately after the injection of
MS or 100 μg LPS into the tunic, a prompt humoral
inflammatory response occurs, as revealed by the increased
Ca2+-independent serum opsonizing activity and HA. The
opsonizing activity reaches its highest levels within 2–4 h
p.i. and then decreases within 12 h, although a high level of
activity is maintained until the end of the experiment (24 h).
A similar enhanced response characterizes the serum HA
against RE. The low titer of Ca2+-independent naturally
occurring hemagglutinins increases significantly just after
MS or LPS injection, reaching their highest values within
4 h. Following this early response, the HA does not
significantly decrease, and high values are maintained until
the end of the experiment, suggesting multiple lectin roles
that may include wound repair. In this respect, the
inflammatory effect of MS injection could be attributable
to the wound stimulus in the tunic matrix, although the
induction could also be a result of bacteria inadvertently
being introduced into the tunic during injections.
Apparently, a timely (within a few minutes) lectin/
opsonin response is stimulated by the trauma caused by
injecting a medium into the tunic, whereas a further
significant inflammatory effect of LPS is manifest (within
4 h), supporting the possibility that serum hemagglutinins
with opsonic properties are upregulated by this inflamma-
tory agent. At 4 h p.i., the opsonizing capacity is
significantly higher in the serum from LPS-treated ascid-
ians, and at that time, the hemagglutinating response is
enhanced (P<0.05). Both hemagglutinin and opsonin
display a binding capacity to the same target, as shown by
absorbing the serum by erythrocytes or yeast.
The galectin nature of inducible lectins is established by
considering both Ca2+-independent activities and D-galac-
tose-binding and D-galactoside-binding (α-lactose, LacNAc,
TDG) specificity. According to Drickamer and Taylor
(1993), Ca2+-independent galectins are characterized by D-
galactoside-specific binding, which is primarily exerted by
LacNAc and TDG, and less so by Lac (Vasta et al. 2004;
Cooper and Barondes 1999).
A controversial result was obtained with D-mannose,
which inhibited the galectin opsonic activity without
affecting the HA. With regards to this, galectins could
occur as oligomers presenting multiple CRDs characterized
by different sugar specificities (Dodd and Drickamer 2001).
CRD variants could be contained in the galectin repertoire
that, like mammalian galectin 10 (Swaminathan et al.
1999), might interact with mannose rather than galactose.
Thus, the possibility exists that, in addition to galectin
opsonizing activity, a mannose receptor is expressed on C.
intestinalis phagocytes.
Since antibodies raised against mammalian IL1 were
used to identify “IL1-like” invertebrate molecules, the sera
showing the highest opsonizing and HA were assayed after
treatment with anti-human recombinant IL1α polyclonal
antibodies. Specific antibodies abolished the opsonizing
activity of S, MS-4h, and LPS-4h and significantly
diminished the HA. The specificity of the antibody reaction
was ascertained by substituting the specific antibodies with
non-specific rabbit IgGs or antisera or with anti-hrIL1α
IgGs absorbed with the specific antigen hrIL1α. The serum
opsonizing capacity never decreased after treatment with
non-specific rabbit IgGs or anti-hrIL1α IgGs absorbed with
hrIL1α, whereas a residual HA could be observed by
naturally occurring non-inducible galactose-specific lectins,
which did not share IL1α epitopes.
An alignment comparison between deduced whole-
length hIL1α (excluding propeptide) and galectin amino
acid sequences reported for the C. intestinalis genome was
not adequate to identify shared epitopes. However two
sequence traits (110–117 and 213–223) of deduced IL1α
amino acid sequence fitted into CRDs of two distinct C.
intestinalis galectins: galectin 235601 CRDI (62.5% simi-
larity) and galectin 216812 CRDII (54.5 % similarity),
respectively. Although very short sequence traits were found,
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the possibility exists that they contribute to galectin steric
configuration, thereby exposing epitopes presumably related
to CRDs. Furthermore, IL1α is known to recognize oligosac-
charide structures by a Ca2+-independent mechanism (Cebo
et al. 2001a, b) suggesting a functional homology with
galectin CRDs.
As shown by SDS-PAGE and immunoblotting analyses,
several serum proteins appear to be modulated in their
expression by the LPS-induced inflammatory response.
Among them, those at 59, 37, 30, 23, and 15 kDa (mean
values, omitting SD) have mainly been identified with the
anti-hrIL1α antiserum, as in the LPS-4h Western blot
pattern.
The 59-kDa, 37-kDa, and 15-kDa cross-reacting proteins
appeared to be mostly upregulated by the inflammatory
response as indicated by their increased density at various
times; density was low at 2 h (LPS-2h), higher at 4 h (LPS-
4h), and not detected in the sera at 8 h and 12 h p.i. The
increase in density of the 37-kDa and 15-kDa proteins was
also visible in the LPS-4h SDS-PAGE pattern. In immuno-
blots, the 23-kDa band was the only band always visible (MS-
4h, LPS-2 to LPS–12h, and S). These results suggest that
proteins presenting IL1α epitopes increase their concentration
in the serum just after an LPS challenge (within 2 h), peak at
4 h, and are promptly involved in the inflammatory response
as indicated by the decreased density of their bands at 8 h and
12 h. The electrophoretic pattern of the sera prepared after MS
injection (MS-4h) revealed 30-kDa, 23-kDa, and 15-kDa
bands at low density, whereas the smallest band was not
visible by immunoblotting analysis. Since serum proteins of
the 6.5-66 size range were examined by SDS-PAGE, no strict
relationship between the equal total protein content of the
various samples and the upregulation of serum components
can be drawn. Finally, the ladders on SDS-PAGE andWestern
blot analysis suggested that enhanced lectins were assembled
into functional highly oligomeric structure. A similar oligo-
merization process has been reported for the humoral
opsonins of the ascidian Pyura stolonifera (Pearce et al.
2001) and a salmon serum lectin (Stratton et al. 2004).
Although we have not been able to identify the lectins
with opsonic properties, our results indicate that the
injection procedure can induce an inflammatory response
by a release of serum proteins that could be related to the
enhanced activity of D-galactoside-specific lectins with
opsonin activity. In addition, a further inflammatory effect
is exerted by LPS that also increases proteins presenting
IL1α epitopes presumably related to an oligomerization
process.
In general terms, the evidence reported here is in accord
with known mammalian cytokine properties of galectins:
(1) galectins are secreted/released from cells when immune
responses are triggered; (2) once released, galectins can
modulate immune responses by cross-linking galectin
ligands on immune cells and targets. In addition, C.
intestinalis galectins probably display pleiotropy and
redundancy, acting as inflammatory cytokines.
In conclusion, C. intestinalis galectins having the
activity of cytokines may be responsible for a functionally
conserved primitive recognition mechanism based on
CDMs contributing to innate defense and inflammatory
reactions in invertebrate and vertebrate immune-evolution.
Research is in progress to isolate, sequence, and character-
ize further these inducible C. intestinalis inflammatory
galectins.
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